HLA allele frequency and clinical outcome in Italian patients with cutaneous melanoma

V. Luongo, G. Pirozzi, C. Caracò, S. Errico, F. De Angelis, E. Celentano, F. Paino, M. G. Chiofalo, M. Luongo, N. Mozzillo, M. L. Lombardi

Research output: Contribution to journalArticlepeer-review


The current study focuses the analysis on the possible relationship between HLA allele frequency and clinical outcome of melanoma in a population of 382 Italian patients, as compared with 203 ethnically matched controls. In a 3-year follow-up study, results showed significant differences between groups of patients selected according to clinical stage, histology, and progression of the disease. A*01 seems to be correlated with a less aggressive variant of the disease, whereas DRB1*01-DQB1*0501 seems to be associated with metastatic progression of melanoma. Moreover, a negative association with B*13, B*44, as well as with DRB1*04-DQB1*0302 was found. A multivariate logistic regression model showed HLA-DRB1*04 to behave as an independent favorable prognostic marker of melanoma in our population (OR = 2.34, CI = 1.15-4.74).

Original languageEnglish
Pages (from-to)84-87
Number of pages4
JournalTissue Antigens
Issue number1
Publication statusPublished - Jul 2004


  • HLA alleles
  • Melanoma

ASJC Scopus subject areas

  • Immunology
  • Cell Biology


Dive into the research topics of 'HLA allele frequency and clinical outcome in Italian patients with cutaneous melanoma'. Together they form a unique fingerprint.

Cite this